Tatva Chintan Pharma Chem Limited announced that at its Board Meeting held on May 5, 2023, the Board Recommended a Final Dividend of INR 2/- (20%) per equity share of INR 10/-each fully paid (subject to deduction of tax, if any) on the equity share capital of INR 22,16,50,620/- (2,21,65,062 equity shares of INR 10/- each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,034 INR | -4.53% | -5.79% | -35.46% |
03/05 | Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024 | |
03/05 | Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.46% | 290M | |
+17.07% | 66.31B | |
-0.29% | 48.46B | |
+21.61% | 43.27B | |
+26.72% | 27.41B | |
+9.25% | 19.26B | |
-2.14% | 16.61B | |
+9.75% | 16.58B | |
-15.01% | 14.41B | |
-30.22% | 14.02B |
- Stock Market
- Equities
- TATVA Stock
- News Tatva Chintan Pharma Chem Limited
- Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2022-23